VivoSeq
Other

Remimazolam

4

Pipeline Programs↗

11

Active Trials↗

2

Companies Involved↗

Remimazolam is an early-stage landscape with 4 programs across 2 companies. The most active players are Acacia Pharma Ltd, Fresenius Kabi Oncology Ltd.. 2 therapies are approved.

Intelligence

Pipeline Metrics

Competitive Density

35/100

Pipeline Velocity

19/100

Mech. Concentration

100/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Acacia Pharma Ltd

1 program

PreclinicalF

Fresenius Kabi Oncology Ltd.

1 program

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

46

clinical trials

Completed27 · 59%
Unknown status8 · 17%
Recruiting5 · 11%
Not yet recruiting5 · 11%
Active, not recruiting1 · 2%

Clinical Trials

Trial Activity

46 trials

Impact of CES1 Genotype on Remimazolam
Recruiting·KKorea University Guro Hospital·N/A·NCT05841667·120 enrolled
Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments
Recruiting·KKaohsiung Veterans General Hospital.·Phase 4·NCT06777758·90 enrolled
Comparison of Remimazolam and Propofol for Recovery of Ambulatory Upper Airway Surgery
Recruiting·—·Phase 4·NCT06507202·116 enrolled
Study on the Feelings of Euphoria Caused by Remimazolam During Gastroscopy and Colonoscopy and Their Related Factors
Recruiting·—·N/A·NCT06721195·305 enrolled
Remimazolam vs Propofol in Laser Burn Cases
Recruiting·MMedical University of South Carolina·Phase 4·NCT07213544·136 enrolled
Combination of Remimazolam and Propofol During Drug-induced Sleep Endoscopy
Active, not recruiting·—·Phase 4·NCT06784479·174 enrolled
Comparison of Remimazolam and Propofol Combination vs. Propofol in IOM
Not yet recruiting·—·Phase 4·NCT06382467·56 enrolled
Remimazolam for Colonoscopy in IBD Patients
Not yet recruiting·HHumanitas Clinical and Research Center·Phase 4·NCT07161297·200 enrolled
Remimazolam in High Risk ERCP Patients
Not yet recruiting·NNational Taiwan University Hospital·N/A·NCT06258356·60 enrolled
Comparison of Efficacy and Safety Between Eleveld PK/PD Model-based Dosing and Standard Dosing During General Anesthesia
Not yet recruiting·SSeoul National University Hospital·Approved·NCT07675850·68 enrolled
The Effect of Intraoperative Remimazolam Administration on the Incidence of Postoperative Acute Kidney Injury After Hepatobiliary and Pancreatic Surgery : a Prospective Randomized Controlled Trial
Not yet recruiting·SSeoul National University Bundang Hospital·Preclinical·NCT07674719·78 enrolled
Effect of Combined Administration of Sevoflurane and Remimazolam on Emergence
Completed·PPusan National University Yangsan Hospital·N/A·NCT06385002·146 enrolled
Reversal of Remimazolam by a Single Dose of Flumazenil
Completed·KKonkuk University Medical Center·N/A·NCT05382806·224 enrolled
Comparison of IONM Between Remimazolam and Propofol
Completed·GGangnam Severance Hospital·N/A·NCT04968054·66 enrolled
Comparison of Remimazolam and Propofol Effect on Oxygen Reserve During Endoscopic Retrograde Cholangiopancreatography
Completed·YYonsei University·N/A·NCT06359834·112 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)